Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
Financials
Financial year 2025
Pharmazym from Waterloo, company number BE1007156740, closed financial year 2025 with a result of € -33,037 after tax. For that financial year Pharmazym recorded a gross margin of € -32,577 and equity of € 210,348. Compared with financial year 2024, the result moved from € -71,615 to € -33,037. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 15, 2026.
€ 210,348
▼ 14% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -33,037
▲ 54 % less loss than in 2024
Profit after tax over the fiscal year.
€ 50,898
▼ 55% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -104,652.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 2,522
▼ 17% vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € -57,678 | € -32,577 | ▲ € 25,101 |
| Profit after taxes | € -71,615 | € -33,037 | ▲ € 38,578 |
| Equity | € 243,385 | € 210,348 | ▼ 14% |
| Total debts | € 3,026 | € 2,522 | ▼ 17% |
| Cash | € 114,083 | € 50,898 | ▼ 55% |
| Retained profit | € -71,615 | € -104,652 | ▼ € 33,037 |
| Balance sheet total | € 246,411 | € 212,870 | ▼ 14% |
Key figures of Pharmazym, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about Pharmazym the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Pharmazym?
What happened at Pharmazym in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 33,037. Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Waterloo. KBO
- Bilqees KHAN became a director. NBB
In short
From € 71,615 loss in 2024 to € 33,037 loss in 2025.
Paid € 13,812 in corporate taxes since 2024.
Management
Behind Pharmazym is Bilqees KHAN. The shares are held by Bilqees KHAN (40%), Jean Rahil KHAN (30%) and Chris KHAN (30%).
Directors
According to the 2025 annual accounts
Bilqees KHAN
Director
Owns 40% directly
since 2024
Shareholders
Bilqees KHAN · director
40%
Jean Rahil KHAN
30%
Chris KHAN
30%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Drève Richelle 161P box 4
1410 Waterloo
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 9 companies are registered at this address.
All companies at this address →Société d'Etudes Techniques au Hainaut
€ 202,726 gross margin · 2025
Floridienne
€ 14.9 million revenue · 2025
GEOPRESS
€ 461,118 gross margin · 2025
CREATIVE WORK
€ 16,608 gross margin · 2025
EOLE Services
€ 3,109 gross margin · 2025
+4 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- KHAN Bilqees(oprichter) 40%
- KHAN Jean Rahil(oprichter) 30%
- KHAN Chris(oprichter) 30%
Details
- Company number
- 1007.156.740
- VAT number
- BE 1007.156.740
- Registered office
- Drève Richelle 161P bus 4, 1410 Waterloo
- Names & denominations
- Pharmazym
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 14 March 2024
- Peppol
- Active · Active since 19 Dec 2025